Literature DB >> 18037182

Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?

Mithra Ghalibafian1, Anne Beaudre, Theodore Girinsky.   

Abstract

BACKGROUND AND
PURPOSE: To increase heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy (IMRT).
MATERIALS AND METHODS: Twenty patients with early-stage mediastinal Hodgkin lymphoma entered the study. IMRT was delivered to the initially involved lymph node volumes. Various virtual volumes (VVs) were designed to improve the protection of the heart and the origin of the coronary arteries, which were the organs at risk (OARs), while preserving adequate PTV coverage. The results obtained with VVs were then compared with those obtained with dose constraints assigned to OARs.
RESULTS: The most satisfactory VV was obtained using the PTV expansion concept. The best compromise between adequate PTV coverage and OAR protection was obtained with dose constraints assigned to the PTV expansion VV and to the origin of the coronary arteries.
CONCLUSIONS: IMRT can be improved by using dose constraints assigned to the PTV expansion VV and/or to the origin of the coronary arteries.

Entities:  

Mesh:

Year:  2007        PMID: 18037182     DOI: 10.1016/j.radonc.2007.10.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Cardiovascular effects after low-dose exposure and radiotherapy: what research is needed?

Authors:  Jan Wondergem; Marjan Boerma; Kazunori Kodama; Fiona A Stewart; Klaus R Trott
Journal:  Radiat Environ Biophys       Date:  2013-09-03       Impact factor: 1.925

Review 2.  Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

Authors:  Stephanie A Terezakis; Yvette L Kasamon
Journal:  Crit Rev Oncol Hematol       Date:  2012-03-29       Impact factor: 6.312

3.  Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques.

Authors:  Laura Cella; Raffaele Liuzzi; Mario Magliulo; Manuel Conson; Luigi Camera; Marco Salvatore; Roberto Pacelli
Journal:  Radiat Oncol       Date:  2010-05-11       Impact factor: 3.481

4.  Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis.

Authors:  Sara Aquino; Marino Clavio; Edoardo Rossi; Luana Vignolo; Maurizio Miglino; Mauro Spriano; Letizia Canepa; Gioacchino Catania; Ivana Pierri; Micaela Bergamaschi; Roberta Gonella; Carlo Marani; Omar Racchi; Marina Cavaliere; Riccardo Goretti; Federico Carbone; Andrea Bruzzone; Rodolfo Tassara; Angelo Michele Carella; Riccardo Ghio; Marco Gobbi
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

5.  Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.

Authors:  Delphine Antoni; Shanti Natarajan-Ame; Philippe Meyer; Claudine Niederst; Khalil Bourahla; Georges Noel
Journal:  Radiat Oncol       Date:  2013-05-02       Impact factor: 3.481

6.  Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerations.

Authors:  Christian Fiandra; Andrea Riccardo Filippi; Paola Catuzzo; Angela Botticella; Patrizia Ciammella; Pierfrancesco Franco; Valeria Casanova Borca; Riccardo Ragona; Santi Tofani; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2012-11-02       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.